Skip to content

Evaluate the Role of Soleus Muscle Exercise in Glycaemic Control in Diabetic Kidney Disease Patients

Evaluate the Role of Soleus Muscle Exercise in Glycaemic Control in Diabetic Kidney Disease Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06120569
Enrollment
45
Registered
2023-11-07
Start date
2024-09-18
Completion date
2024-10-31
Last updated
2023-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Kidney Disease

Brief summary

Evaluate the role of Soleus muscle exercise in management diabetic kidney disease

Detailed description

management of diabetic kidney disease. To enhance their glycemic control, diabetic patients are advised to perform 150 minutes per week of moderate-to-vigorous aerobic activity Diabetic patients with regular physical activity have reduced daily insulin dose with more glycemic control. In addition to glycemic control, it has also been postulated that the addition of brief intervals of high intensity, sprint -type exercise to aerobic exercise can decrease the risk of late nocturnal hypoglycemic episodes Marc T. Hamilton et al., 2022, reported that the human soleus muscle could raise local oxidative metabolism to high levels for hours without fatigue, during a type of soleus-dominant activity while sitting (soleus push up exercise), even in unfit volunteers. They reported that soleus push up exercise can improve systemic VLDL-triglyceride and glucose homeostasis by a large magnitude, e.g., 52% less postprandial glucose excursion (∼50 mg/dL less between ∼1 and 2 h) with 60% less hyperinsulinemia. Muscle biopsies revealed there was minimal glycogen use. This can be explained that the soleus doesn't rely completely on intramuscular glycogen, Instead, it uses a mixture of fuels from glucose and lipoproteins.

Interventions

DEVICESoleus ms exercise

Soleus muscle exercise before and after eating by half an hour

Sponsors

Nora Hussein Kamal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients age 18-60 yrs., * patients with Diabetic kidney disease, not on dialysis * with stabilized diabetic treatment regimen for 3 months before participating in the study

Exclusion criteria

* advanced osteoarthritis of lower limb joints * advanced poly neuropathic patients * CKD type V on dialysis * Diabetic Foot * hemophilia * bleeding tendency * AKI * other causes of chronic kidney disease * patients refuse to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
HbA1C less than 7%One yearImprove HbA1c by soleus muscle exercise

Secondary

MeasureTime frameDescription
ratio of albumin (mcg/L) to creatinine (mg/L)ratioOne yearImprove alb /creatinine ratio

Contacts

Primary ContactNora Kamal, Resident
norahussein097@gmail.com01002380242
Backup ContactAshraf El - Shazly, Prof
Ashrafshazly58@gmail.com01062879221

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026